Join us in transforming medical device clinical research with innovative AI-powered solutions and a proven track record of excellence
Eclevar is a CRO created in 2018 and based in Paris La Défense. We work across the entire value chain of medical device development, through complementary services tailored to our clients' challenges. We offer customized service, personalized to the need of our clients. Whether you are looking for full service CRO or staffing clinical or regulatory experts, our management team with more than 20 years experience will drive you to the effective solution.
Eclevar is a team of passionate experts with strong skills and experience in their field of expertise. Our team is composed of multilingual professionals who have worked in the medical device, pharmaceutical, CRO and notified body industries.
We combine deep regulatory expertise with cutting-edge technology to deliver exceptional results for our clients across Europe, Asia, and beyond.
MILO Healthcare is our AI-powered, all-in-one EDC platform for medical device trials, featuring eCRF, ePRO, eConsent, Survey, Cohorts, and Randomization modules. Fully compliant with 21 CFR Part 11, ICH-GCP, GDPR, HIPAA, HL7 FHIR, OMOP CDM, and DICOM.
With the EU MDR creating unprecedented demand for clinical evidence, we're positioned at the intersection of regulatory compliance and technological innovation. Our clients span cardiovascular, orthopedic, wound care, and other high-growth therapeutic areas.
Our management team brings over 20 years of combined experience in medical devices, clinical research, and regulatory affairs. Led by CEO Chems Hachani and supported by world-class advisors including Prof. Luc Teot and Dr. Nikhil Khadabadi.
Operating across France, UK, Germany, Japan, and Australia, we offer localized expertise with global standards. Our multilingual team navigates complex regulatory landscapes including EU MDR, PMDA, TGA, and FDA requirements.
Our dual revenue streams—CRO services and MILO Healthcare platform subscriptions—create a scalable, recurring revenue model. Platform pricing ranges from €500/month to €3,000/month for unlimited studies.
With an average client relationship of 12 months and testimonials from industry leaders like Ossur, RegenLab, Pfizer, and CHU Montpellier, we've built lasting partnerships based on exceptional service delivery.
Join us in transforming medical device clinical research and making a real impact on healthcare outcomes worldwide
Schedule a Meeting with Our Leadership
